Waters (NYSE:WAT – Get Free Report) posted its earnings results on Wednesday. The medical instruments supplier reported $4.10 EPS for the quarter, topping analysts’ consensus estimates of $4.02 by $0.08, Zacks reports. Waters had a return on equity of 49.93% and a net margin of 21.43%. Waters updated its Q1 2025 guidance to 2.170-2.250 EPS and its FY 2025 guidance to 12.700-13.000 EPS.
Waters Trading Down 6.7 %
Waters stock traded down $27.23 during trading hours on Wednesday, hitting $378.07. The company had a trading volume of 652,695 shares, compared to its average volume of 421,214. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.38 and a current ratio of 2.02. The firm has a market cap of $22.45 billion, a P/E ratio of 36.10, a P/E/G ratio of 7.37 and a beta of 1.01. The company has a 50-day moving average price of $390.34 and a two-hundred day moving average price of $363.72. Waters has a 1 year low of $279.24 and a 1 year high of $423.56.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the stock. Scotiabank started coverage on shares of Waters in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $430.00 price objective for the company. Sanford C. Bernstein upgraded Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price target for the company in a research report on Friday, January 10th. TD Cowen upped their price objective on Waters from $363.00 to $410.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Wells Fargo & Company lifted their target price on Waters from $380.00 to $415.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Finally, Cfra set a $389.00 price target on Waters in a report on Thursday, October 17th. Ten investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Waters presently has a consensus rating of “Hold” and a consensus price target of $388.64.
About Waters
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
See Also
- Five stocks we like better than Waters
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Inflation Persists, But So Do Stock Opportunities: Rally On
- 3 REITs to Buy and Hold for the Long Term
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
- 3 Tickers Leading a Meme Stock Revival
- Shopify Confirms Stock Uptrend, New Highs in Sight
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.